Expected 1H’26 Results:
- 1H’26 revenues expected to grow 50% to approximately
$5M vs.$3.3M in 1H’25 - Positive net income expected in 1H’26 vs.
$1.9M net loss in 1H’25 - Cash position at the close of 1H’26 is expected to remain in line with
$2.7M at year-end 2025
Q1’26 & Q2’26 Expected Revenues:
- Q1’26 revenues expected to grow 37% to
$2.2M vs.$1.6M in Q1’25 - Q2’26 revenues expected to grow 65% to
$2.8M vs.$1.7M in Q2’25
BIO-key’s improved 1H’26 results reflect the benefit of a
BIO-key CEO,
“These developments underscore the demand we are creating directly and via partners, particularly in regions with favorable regulatory frameworks. Through disciplined management of margins and overhead, we expect our top-line growth to translate into meaningful improvement on the net income line and in our ability to fund further growth.”
About
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.
BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue; our ability to raise additional capital to satisfy working capital needs; our ability to continue as a going concern; our ability to protect our intellectual property; changes in business conditions; changes in our sales strategy and product development plans; changes in the marketplace; continued services of our executive management team; security breaches; competition in the biometric technology and identity access management industries; market acceptance of biometric products generally and our products under development; our ability to convert sales opportunities to customer contracts; our ability to expand into
| Engage with BIO-key | |
| Facebook – Corporate: | https://www.facebook.com/BIOkeyInternational/ |
| LinkedIn – Corporate: | https://www.linkedin.com/company/bio-key-international |
| X – Corporate: | @BIOkeyIntl |
| X – Investors: | @BIO_keyIR BIO_keyIR |
Investor Contacts
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800
Source: 